ANIP vs CMPR Comparison

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Cimpress PLC helps millions of businesses build brands, stand out, and grow via customized physical marketing products and branded merchandise. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. It has five segments VistaPrint, PrintBrothers, The Print Group, National Pen, and All Other Businesses. Majority of revenue comes from VistaPrint segment which provides graphic design services, VistaCreate for do-it-yourself (DIY) design, etc. It has presence in North America, Europe, and Other. The company generates majority of revenue is from Europe.